Merging AI and synthetic biology

Researchers create a protein fiber that records cell activities over time, helping scientists study large groups of cells and uncover details about brain functions and diseases.

A NASA-funded study tests whether fungi can grow with planetary regolith to form strong building materials for lunar and Martian bases.

"NANITE" strategy amplifies genome editing in vivo by turning transfected cells into temporary factories that deliver Cas9 to their neighbors.

In 2025, biotech paired real clinical breakthroughs with harsh commercial reality, forcing the sector to abandon long-term narratives in favour of near-term revenue, scalability, and regulatory survival.

Breakthrough uses directed evolution to develop versatile tool for medicine and research, overcoming natural limits of DNA-copying enzymes.

Researchers develop a biodegradable artificial synapse that uses less energy than the human brain, enabling sustainable neuromorphic electronics and temporary intelligent devices.

Anthrobots: Where human cells become self-assembling, tissue-repairing biobots. Is this the dawn of cellular medicine’s next frontier?

A Boston startup gains FDA approval to begin the first clinical trial using cellular reprogramming to treat eye disease, with potential implications for reversing aspects of aging.